Trials / Terminated
TerminatedNCT03147040
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer: GELATO-trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- The Netherlands Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm multicenter non-randomized phase II trial testing the efficacy of the combination of carboplatin plus atezolizumab in metastatic ILC
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carboplatin | Chemotherapy treatment with carboplatin and atezolizumab |
| DRUG | Atezolizumab | Chemotherapy treatment with carboplatin and atezolizumab |
Timeline
- Start date
- 2017-11-02
- Primary completion
- 2022-05-01
- Completion
- 2022-07-01
- First posted
- 2017-05-10
- Last updated
- 2022-07-19
Locations
4 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03147040. Inclusion in this directory is not an endorsement.